IllustrativeFDA approves Lilly obesity pill, triggering battle with Novo Nordisk
✦ NabkaNews BriefAuto-summarized from multiple outlets · verify with the source
The FDA has approved an obesity pill made by Lilly, which may lead to competition with Novo Nordisk. This approval could potentially trigger a battle between the two companies. The nature and implications of this battle are not yet clear.